Log In
Print this Print this

tretinoin (Vesanoid)

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionOral formulation of a vitamin A derivative
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAcute promyelocytic leukemia (APL)
Indication DetailsTreat acute promyelocytic leukemia (APL)
Regulatory Designation
PartnerChugai Pharmaceutical Co. Ltd.;
Fuji Pharma Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today